STOCK TITAN

ADMA Biologics (ADMA) Total Assets by Year

ADMA NASDAQ

ADMA Biologics, Inc. closed fiscal year 2025 with $624.2M in total assets, $146.9M in total liabilities and $477.3M in shareholder equity. Total assets rose 27.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters ADMA Biologics, Inc. has filed alongside them.

FY2025 annual
Total Assets $624.2M
Total Liabilities $146.9M
Total Equity $477.3M
YoY +27.7%
5Y CAGR +24.6%
10Y CAGR +38.7%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ADMA Balance Sheet by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FilingFY21FilingFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Total Assets$624.2M+27.7%$488.7M+48.5%$329.2M-5.5%$348.5M+26.1%$276.3M+33.0%$207.7M+63.4%$127.1M+43.0%$88.9M-17.7%$108.0M+356.1%$23.7M-0.1%$23.7M-12.2%$27.0M-15.5%$32.0M+105.6%$15.6M+431.6%$2.9M
Total Liabilities$146.9M+5.2%$139.7M-28.0%$194.0M-1.3%$196.5M+45.5%$135.1M+13.1%$119.4M+18.4%$100.9M+46.0%$69.1M+2.1%$67.7M+140.5%$28.1M+22.9%$22.9M+8.9%$21.0M+101.9%$10.4M+69.7%$6.1M+141.4%$2.5M
Total Equity$477.3M+36.8%$349.0M+158.1%$135.2M-11.0%$152.0M+7.7%$141.2M+60.0%$88.2M+236.9%$26.2M+32.5%$19.8M-51.0%$40.3Mn/m-$4.5M-642.9%$821K-86.3%$6.0M-72.1%$21.6M+128.9%$9.4M+2342.5%$386K

ADMA Balance Sheet by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Total Assets$732.5M+28.8%$684.2M+22.5%$665.2M+30.3%$624.2M+27.7%$568.7M+45.6%$558.4M+48.3%$510.6M+45.5%$488.7M+48.5%$390.6M+11.9%$376.4M+9.7%$350.9M+3.0%$329.2M-5.5%
Total Liabilities$294.0M+113.8%$276.0M+72.4%$274.9M+100.4%$146.9M+5.2%$137.5M-13.4%$160.1M-14.9%$137.2M-30.4%$139.7M-28.0%$158.7M-19.7%$188.1M-4.1%$197.2M+1.0%$194.0M-1.3%
Total Equity$438.5M+1.7%$408.2M+2.5%$390.3M+4.5%$477.3M+36.8%$431.2M+85.9%$398.3M+111.6%$373.4M+142.9%$349.0M+158.1%$231.9M+53.1%$188.3M+28.3%$153.7M+5.5%$135.2M-11.0%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More ADMA Biologics, Inc. financials

Frequently Asked Questions

ADMA Biologics, Inc. closed fiscal year 2025 with $624.2M in total assets, $146.9M in total liabilities and $477.3M in shareholder equity.

ADMA Biologics, Inc. (ADMA) total assets rose by 27.7% year over year, from $488.7M to $624.2M in fiscal year 2025.

Across the 15 fiscal years this page covers, ADMA Biologics, Inc. (ADMA) total assets went from $2.9M in fiscal year 2011 to $624.2M in fiscal year 2025.

ADMA Biologics, Inc. (ADMA) reported $732.5M in total assets in Q3 2026. This represents an increase of 28.8% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what ADMA Biologics, Inc. (ADMA) reported on that line in every period on record.